176 related articles for article (PubMed ID: 18722669)
21. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
[TBL] [Abstract][Full Text] [Related]
22. Ribavirin treatment for Crimean-Congo hemorrhagic fever.
Leblebicioglu H
Jpn J Infect Dis; 2009 Nov; 62(6):485-6; author reply 486. PubMed ID: 20058332
[No Abstract] [Full Text] [Related]
23. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy.
Ozkurt Z; Kiki I; Erol S; Erdem F; Yilmaz N; Parlak M; Gundogdu M; Tasyaran MA
J Infect; 2006 Mar; 52(3):207-15. PubMed ID: 15953646
[TBL] [Abstract][Full Text] [Related]
24. Ethical concern.
Doganci L
J Infect; 2009 Oct; 59(4):289-90; author reply 290-1. PubMed ID: 19647019
[No Abstract] [Full Text] [Related]
25. Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers.
Ergönül Ö; Keske Ş; Çeldir MG; Kara İA; Pshenichnaya N; Abuova G; Blumberg L; Gönen M
Emerg Infect Dis; 2018 Sep; 24(9):1642-1648. PubMed ID: 30124196
[TBL] [Abstract][Full Text] [Related]
26. Treatment and prophylaxis with ribavirin for Crimean-Congo Hemorrhagic Fever--is it effective?
Bangash SA; Khan EA
J Pak Med Assoc; 2003 Jan; 53(1):39-41. PubMed ID: 12666854
[No Abstract] [Full Text] [Related]
27. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
Duygu F; Kaya T; Baysan P
Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
[TBL] [Abstract][Full Text] [Related]
28. Ribavirin Had Demonstrable Effects on the Crimean-Congo Hemorrhagic Fever Virus (CCHFV) Population and Load in a Patient With CCHF Infection.
Espy N; Pérez-Sautu U; Ramírez de Arellano E; Negredo A; Wiley MR; Bavari S; Díaz Menendez M; Sánchez-Seco MP; Palacios G
J Infect Dis; 2018 May; 217(12):1952-1956. PubMed ID: 29584885
[TBL] [Abstract][Full Text] [Related]
29. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
Hawman DW; Haddock E; Meade-White K; Williamson B; Hanley PW; Rosenke K; Komeno T; Furuta Y; Gowen BB; Feldmann H
Antiviral Res; 2018 Sep; 157():18-26. PubMed ID: 29936152
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.
Oestereich L; Rieger T; Neumann M; Bernreuther C; Lehmann M; Krasemann S; Wurr S; Emmerich P; de Lamballerie X; Ölschläger S; Günther S
PLoS Negl Trop Dis; 2014 May; 8(5):e2804. PubMed ID: 24786461
[TBL] [Abstract][Full Text] [Related]
31. Bradycardia related to ribavirin in four pediatric patients with Crimean-Congo hemorrhagic fever.
Tezer H; Ozkaya Parlakay A; Gülhan B; Cetin I
Vector Borne Zoonotic Dis; 2014 Jun; 14(6):464-5. PubMed ID: 24745325
[TBL] [Abstract][Full Text] [Related]
32. A case of Crimean-congo hemorrhagic fever with pleural effusion.
Tanir G; Tuygun N; Balaban I; Doksöz O
Jpn J Infect Dis; 2009 Jan; 62(1):70-2. PubMed ID: 19168966
[TBL] [Abstract][Full Text] [Related]
33. Crimean-Congo hemorrhagic fever.
Mardani M; Keshtkar-Jahromi M
Arch Iran Med; 2007 Apr; 10(2):204-14. PubMed ID: 17367225
[TBL] [Abstract][Full Text] [Related]
34. Nosocomial outbreak of Crimean-Congo haemorrhagic fever.
Naderi HR; Sarvghad MR; Bojdy A; Hadizadeh MR; Sadeghi R; Sheybani F
Epidemiol Infect; 2011 Jun; 139(6):862-6. PubMed ID: 20800007
[TBL] [Abstract][Full Text] [Related]
35. High-dose methylprednisolone in children with Crimean-Congo haemorrhagic fever.
Dilber E; Cakir M; Erduran E; Koksal I; Bahat E; Mutlu M; Celtik AY; Okten A
Trop Doct; 2010 Jan; 40(1):27-30. PubMed ID: 20075424
[TBL] [Abstract][Full Text] [Related]
36. Genetic detection and isolation of crimean-congo hemorrhagic fever virus, Kosovo, Yugoslavia.
Papa A; Bozovi B; Pavlidou V; Papadimitriou E; Pelemis M; Antoniadis A
Emerg Infect Dis; 2002 Aug; 8(8):852-4. PubMed ID: 12141973
[TBL] [Abstract][Full Text] [Related]
37. Genotoxic effect of ribavirin in patients with Crimean-Congo hemorrhagic fever.
Tatar A; Ozkurt Z; Kiki I
Jpn J Infect Dis; 2005 Oct; 58(5):313-5. PubMed ID: 16249628
[TBL] [Abstract][Full Text] [Related]
38. Crimean-Congo hemorrhagic fever in Southeast of Iran.
Alavi-Naini R; Moghtaderi A; Koohpayeh HR; Sharifi-Mood B; Naderi M; Metanat M; Izadi M
J Infect; 2006 May; 52(5):378-82. PubMed ID: 16182370
[TBL] [Abstract][Full Text] [Related]
39. Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells.
Andersson I; Lundkvist A; Haller O; Mirazimi A
J Med Virol; 2006 Feb; 78(2):216-22. PubMed ID: 16372299
[TBL] [Abstract][Full Text] [Related]
40. Do we really need ribavirin in the treatment of crimean-congo hemorrhagic Fever?
Kalın G; Metan G; Demiraslan H; Doganay M
J Chemother; 2014 Jun; 26(3):146-9. PubMed ID: 24091085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
